Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1716801

registered interest
date	09/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicine: Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will hold discussions with the (a) Medical Schools Council and (b) British Medical Association on the effectiveness of preference-informed allocation for foundation placements for medical graduates.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	25505
answer	answer is ministerial correction date of answer 15/05/2024 answer text <p>The UK Foundation Programme Office (UKFPO) manages the national application process for the UK Foundation Programme, on behalf of the four statutory education bodies for the United Kingdom. The UKFPO changed the allocation process for the programme this year to a Preference Informed Allocation method. This consisted of applicants being given a computer-generated rank, and removed the requirement for them to sit the Situational Judgement Test. This change was based on engagement with stakeholders, including the Medical Schools Council, and the British Medical Association.</p><p>When confirming the move to the new system last year, the UKFPO set out that once implemented, it would be kept under constant review, to make sure it is working well for applicants. The UKFPO has confirmed that 75% of applicants received their first choice of programme this year, a 4% increase on last year.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/05/2024 15:44:06 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1716806

registered interest
date	09/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the adequacy of the availability of enzyme replacement therapy.
tabling member constituency	Jarrow
tabling member printed	Kate Osborne
uin	25591
answer	answer is ministerial correction date of answer 15/05/2024 answer text <p>We are aware of the supply issues with the three enzyme replacement therapies, Creon 10,000 gastro-resistant capsules, Creon 25,000 gastro-resistant capsules, and Nutrizym 22 capsules. These are due to manufacturing and active pharmaceutical ingredient constraints. The Department will be issuing updated guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products to help drive the resolution of these issues as quickly as possible, for example by expediting orders and increasing forecasts. We are also working with specialist importers to source unlicensed imports from abroad.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 25370 25371 question first answered 15/05/2024 08:18:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4783 label Biography information for Kate Osborne

1716362

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer: Artificial Intelligence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 May 2024 to Question 24269 on Lung Cancer: Artificial Intelligence, which (a) NHS trusts have and (b) imaging network has not received funding.
tabling member constituency	Hove
tabling member printed	Peter Kyle
uin	25291
answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Since the initial announcements regarding funding for National Health Service trusts to integrate artificial intelligence into lung cancer imaging, adjustments have been made to the list of participants. Three trusts have withdrawn from the initiative, and five additional trusts have been onboarded, due to the inclusion of a new imaging network. As a result, as set out in the answer of 7 May 2024, there are now 66 trusts across 12 imaging networks that are participating in this initiative.</p><p>In the answer of 7 May 2024, 63 out of 66 trusts, in 11 of 12 imaging networks, had received funding. It is now confirmed that all 66 trusts in the 12 imaging networks participating have received or are in the process of receiving funding. These trusts are currently implementing artificial intelligence technologies to enhance diagnostic capabilities in lung cancer, consistent with the Government's commitment to advancing healthcare technology across the NHS.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:24:50 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4505 label Biography information for Peter Kyle

1716387

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospices: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of amending the funding model for hospices.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	25324
answer	answer is ministerial correction date of answer 15/05/2024 answer text <p>Integrated care boards (ICBs) are responsible for determining the level of National Health Service-funded palliative and end of life care, including hospice care, locally, and they are responsible for ensuring that the services they commission meet the needs of their local population. As part of the Health and Care Act 2022, the Government added palliative care services to the list of services an ICB must commission, which will ensure a more consistent national approach, and support commissioners in prioritising palliative and end of life care.</p><p>The majority of palliative and end of life care is provided by NHS staff and services. However, we also recognise the vital part that voluntary sector organisations, including hospices, play in providing support to people at end of life, and their families. Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding hospices receive is dependent on many factors, including what other statutory services are available within the ICB footprint. Charitable hospices provide a range of services which go beyond that which statutory services are legally required to provide. Consequently, the funding arrangements reflect this.</p><p>The Department, alongside key partners, and NHS England will continue to engage with stakeholders, including the voluntary sector and independent hospices on an ongoing basis, in order to understand the issues they face, including that of future funding pressures. The Department is in ongoing discussions with NHS England about oversight and accountability of National Health Service palliative and end of life care commissioning.</p><p>The Government recognises the difficult economic context that organisations such as hospices face, which is why we made the decision to provide additional funding to help deliver non-consolidated pay awards to eligible staff employed by non-NHS organisations, including some hospices. Funding has been made available for over 27,000 staff in non-NHS organisations to receive the two non-consolidated awards agreed as part of the Agenda for Change pay deal. Eligible organisations will receive their funding as soon as practically possible, following the receipt of their invoice.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 25325 question first answered 15/05/2024 16:51:04 answering member 4527 label Biography information for Helen Whately
tabling member	4676 label Biography information for Marsha De Cordova

1716388

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospices: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to support hospices with rising costs.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	25325
answer	answer is ministerial correction date of answer 15/05/2024 answer text <p>Integrated care boards (ICBs) are responsible for determining the level of National Health Service-funded palliative and end of life care, including hospice care, locally, and they are responsible for ensuring that the services they commission meet the needs of their local population. As part of the Health and Care Act 2022, the Government added palliative care services to the list of services an ICB must commission, which will ensure a more consistent national approach, and support commissioners in prioritising palliative and end of life care.</p><p>The majority of palliative and end of life care is provided by NHS staff and services. However, we also recognise the vital part that voluntary sector organisations, including hospices, play in providing support to people at end of life, and their families. Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding hospices receive is dependent on many factors, including what other statutory services are available within the ICB footprint. Charitable hospices provide a range of services which go beyond that which statutory services are legally required to provide. Consequently, the funding arrangements reflect this.</p><p>The Department, alongside key partners, and NHS England will continue to engage with stakeholders, including the voluntary sector and independent hospices on an ongoing basis, in order to understand the issues they face, including that of future funding pressures. The Department is in ongoing discussions with NHS England about oversight and accountability of National Health Service palliative and end of life care commissioning.</p><p>The Government recognises the difficult economic context that organisations such as hospices face, which is why we made the decision to provide additional funding to help deliver non-consolidated pay awards to eligible staff employed by non-NHS organisations, including some hospices. Funding has been made available for over 27,000 staff in non-NHS organisations to receive the two non-consolidated awards agreed as part of the Agenda for Change pay deal. Eligible organisations will receive their funding as soon as practically possible, following the receipt of their invoice.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 25324 question first answered 15/05/2024 16:51:04 answering member 4527 label Biography information for Helen Whately
tabling member	4676 label Biography information for Marsha De Cordova

1716397

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Packaging
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will take steps to stop child friendly packaging being used to advertise unhealthy food to children.
tabling member constituency	Sheffield Central
tabling member printed	Paul Blomfield
uin	25204
answer	answer is ministerial correction date of answer 16/05/2024 answer text <p>The Government is committed to working with businesses to ensure that we create the conditions for a healthier nation, and we are implementing an ambitious programme of measures to tackle childhood obesity. On 1 October 2022, the Government introduced legislation to restrict the location of foods high in fat, salt, or sugar in shops and online. These restrictions will have the single biggest impact on reducing children’s calorie consumption, and are expected to accrue health benefits of over £57 billion, and provide the National Health Service savings of over £4 billion, over the next 25 years.</p><p>On 1 October 2025, the volume price promotion restrictions will come into force, restricting volume price promotions such as three for two offers on less healthy products. The Government will simultaneously introduce a United Kingdom-wide 9:00pm television watershed for products high in fat, salt, or sugar, and a restriction of paid-for advertising of these products online, also on 1 October 2025. We continue to work with industry on the Food Data Transparency Partnership, to co-develop voluntary reporting requirements for food business to demonstrate the healthiness of their sales.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 16/05/2024 11:17:21 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4058 label Biography information for Paul Blomfield

1716406

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many women were diagnosed with ovarian cancer by age in each of the last three years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	25217
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The following link shows the numbers of women diagnosed with ovarian cancer by age in England, each year between 2019 and 2021, the most recent year for which we have data:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2021---summary-counts-only" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2021---summary-counts-only</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:25:59 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1716417

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Maternity Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will take steps to implement the recommendations of MBRRACE-UK's report entitled Saving Lives, Improving Mothers’ Care: Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2019-21, published in October 2023.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	25319
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The recommendations made in the Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK’s (MBRRACE-UK) report have informed a series of work programmes to improve maternity safety. This includes ongoing work delivered through NHS England's Three-Year Delivery Plan for Maternity and Neonatal Services, which sets out how care will be made safer, more personalised, and more equitable for women, babies, and families. This is supported by an additional investment of £186 million a year to improve maternity and neonatal care, compared to 2021, on top of an additional £35 million over three years, from 2024/25 to 2026/27.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/05/2024 10:56:54 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1716419

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Maternity Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure that NHS England facilitates the dissemination of the findings of the maternal, newborn and infant clinical outcome review programme delivered by MBRRACE-UK.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	25320
answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The maternal, newborn, and infant clinical outcome review programme, delivered by Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK), forms part of the National Clinical Audit and Patient Outcomes Programme, which is commissioned and managed on behalf of NHS England by the Healthcare Quality Improvement Partnership.</p><p>MBRRACE-UK publishes annual data and surveillance reports on their website, and holds a national learning event to disseminate information and audit findings. NHS England supports this approach and reviews all audit recommendations after publication with a range of stakeholders. NHS England’s Three-Year Delivery Plan for Maternity and Neonatal services also highlights how NHS England will use MBRRACE-UK’s reports to monitor trends and themes at both a national and local level.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/05/2024 10:59:40 answering member 4492 label Biography information for Maria Caulfield
tabling member	4657 label Biography information for Anneliese Dodds

1716421

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions she (a) has had and (b) plans to have with (i) charities and (ii) other organisations working to secure UK access to new drugs for (A) incurable, (B) relapsing and (C) remitting cancers such as myeloma.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	25238
answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Department ministers and officials regularly meet with a range of organisations, with an interest in securing patient access to new cancer medicines. The National Institute for Health and Care Excellence (NICE) is the body that develops authoritative, evidence-based guidance for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits, including medicines for myeloma. The NICE aims to publish guidance on all new medicines close to the point of licensing wherever possible, and has recommended many cancer medicines for NHS use that are now available to NHS patients, including through the Cancer Drugs Fund.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:43:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4370 label Biography information for Jess Phillips